HRT Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
HRT Financial's ARKG Position: Q3 2026 in Review
HRT Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2026, closing a stake of 177,780 shares — an estimated $7.48M sold.
HRT Financial first reported a position in ARKG in Q4 2020 and held it in 13 quarters. The position peaked at $33.5M in Q2 2021. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- HRT Financial reported no remaining ARK Genomic Revolution ETF position as of Q3 2026 after selling out during the quarter.
- HRT Financial sold 177,780 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $7.48M.
- HRT Financial first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 13 quarters.
- HRT Financial's ARK Genomic Revolution ETF position peaked at $33.5M in Q2 2021.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.